A defesa da concorrência no setor farmacêutico: litígios e acordos anticoncorrenciais
Article Sidebar
Main Article Content
Abstract
This article examines two types of potentially anti-competitive conducts involving the pharmaceutical industry: abusive judicial and administrative proceedings for the extension of patents on drugs, and agreements between reference drugs manufacturers and generic drugs manufacturers to terminate litigation related to patents. After a brief incursion in international experience relating to these conducts, within the scope of highlighting the harmful effects they produce on market and competition, we describe parameters for the treatment of these conducts in Brazilian law, ínferring alternatives able to protect competition in the harmaceutical sector.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Barbosa, Denis Borges. Atividade inventiva: objetividade do exame. Disponível cm: [www.denisbarbosa.addr.com/alividade.pdfl. Acesso em: 10.09.2012.
Coleman, Deborah. Antitrust issues in lhe litigalion and settlement of infringement claims. Akron Law Review. vol. 37. 2004.
Comparato, Fábio Kondcr. A transferência empresarial de tecnologia para países subdesenvolvidos: um caso típico de inadequação dos meios aos fins. Revista de Direito Mercantil, Industrial, Económico e Financeiro, n. 47. ano XXI. 1982.
Cotter, Thomas. Antitrust implications of patent settlements involving reverse payments: defending a rebuttable presumption of illegality in light of some recent scholarship. Antitrust Law Journal, vol. 71. 2004.
Dolin, Gregory. Reverse settlements as patent invalidity signals. HarvardJournal of Law & Technology, vol. 24. n. 2. 2011.
European Comission. 3rd Report on the Monitoring ofPatent Settlements- Period: January-December 2011. 25.07.2012. Disponível em: [http://ec.europa.eu/ competition/sectors/pharmaceulicals/inquiry/patent_settlements_report3_ en.pdfj. Acesso em: 05.10.2012.
Federal Trade Comission. Generic drug entry prior to patent expiration. jul. 2002. Disponível em: [www.ftc.gov/os/2002/07/genericdrugstudy.pdf). Acesso em: 13.09.2012.
. Pay-for-delay: How drug company pay-offs cost consumer billions. jan. 2010. Disponível em: [www.ftc.gov/os/20l0/01/100112payfordelayrpt.pdfl. Acesso em: 08.09.2012.
Hemphill, C. Scott. Paying for delay: pharmaceutical patent settlement as a regulatory design problem. New York University Law Review. vol. 81. 2006.
Fagerlund, Niklas; Rasmussen, Soren Bo. AstraZcneca: the first abuse case in the pharmaceutical sector. Competition Policy Newsletter. n. 3. 2005.
Hovenkamp, Herbert. Antitrust and patent law analysis of pharmaceutical reverse payment settlements. 2011. Disponível em: [http://ssrn.com/abstract=1741162]. Acesso em: 03.08.2012.
Martinez, Ana Paula. Concorrência e propriedade intelectual, apresentação à Federação das Indústrias do Estado de São Paulo - Fiesp. jun. 2011. Disponível em: [www.fiesp.com.br]. Acesso em: 04.10.2012.
Motta, Ricardo Casanova. O lançamento de medicamento genérico, pelo detentor da patente, antes do fim da proteção patenlária: uma análise concorrencial. Revista do Ibrac — Direito da Concorrência, Consumo e Comércio Internacional, vol. 20. p. 111. São Paulo: Ed. RT, jul. 2011.
Salomão Filho, Calixto. Direito concorrencial: as condutas. São Paulo: Malheiros, 2003.
Schildkraut, Mark. Patent-splitting settlements and the reverse payment fallacy. Antitrust LawJournal. vol. 71. p. 1034-1068.
Shapiro, Cari. Antitrust limits to patent settlements. RandJournal of Economics. vol. 34. n. 2. p. 391-411. 2003.
Salles, Carlos Alberto de. Mecanismos alternativos de solução de controvérsias e acesso à Justiça: a inafastabilidade da tutela jurisdicional recolocada. In: Fux, Luiz; Nery Jr., Nelson; Arrud/ Alvim Wambier, Teresa (coords.). Processo e Constituição: estudos em homenagem ao ProfessorJosé Carlos Barbosa Moreira. São Paulo: Ed. RT, 2006.
Silva, Virgílio Afonso da. O proporcional e o razoável. Revista dos Tribunais, vol. 798. p. 23. São Paulo: Ed. RT, abr. 2002.
U.S. Department of Justice & Federal Trade Comission. Antitrust guidelines for the licensing of intellectual property. 1995. Disponível em: [www.ftc.gov/ bc/0558.pdf]. Acesso em: 09.09.2012.
Vardner, Joseph. The Statutory Presumption of Patent Validity in Antitrust Cases. HarvardJournal ofLaw & Technology, vol. 25. 2011.